Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
To assess the genetics of hyperlipidemia in coronary heart disease, family studies were carried out in 2520 relatives and spouses of 176 survivors of myocardial infarction, including 149 hyperlipidemic and 27 normolipidemic individuals. The distribution of fasting plasma cholesterol and triglyceride values in relatives, together with segregation analyses, suggested the presence of five distinct lipid disorders. Three of these-familial hypercholesterolemia, familial hypertriglyceridemia, and familial combined hyperlipidemia-appeared to represent dominant expression of three different autosomal genes, occurring in about 20% of survivors below 60 yr of age and 7% of all older survivors. Two other disorders-polygenic hypercholesterolemia and sporadic hypertriglyceridemia-each affected about 6% of survivors in both age groups. The most common genetic form of hyperlipidemia identified in this study has hitherto been poorly defined and has been designated as familial combined hyperlipidemia. Affected family members characteristically had elevated levels of both cholesterol and triglyceride. However, increased cholesterol or increased triglyceride levels alone were also frequently observed. The combined disorder was shown to be genetically distinct from familial hypercholesterolemia and familial hypertriglyceridemia for the following reasons: (a) the distribution pattern of cholesterol and triglyceride levels in relatives of probands was unique; (b) children of individuals with combined hyperlipidemia did not express hypercholesterolemia in contrast to the finding of hypercholesterolemic children from families with familial hypercholesterolemia; and (c) analysis of informative matings suggested that the different lipid phenotypes owed their origin to variable expression of a single autosomal dominant gene and not to segregation of two separate genes, such as one elevating the level of cholesterol and the other elevating the level of triglyceride. Heterozygosity for one of the three lipid-elevating genes identified in this study may have a frequency in the general population of about 1%, constituting a major problem in early diagnosis and preventive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease: The Framingham Study
KANNEL, W. B., CASTELLI, W. P., GORDON, T., & MCNAMARA, P. M. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,057
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,818
The inheritance of liability to certain diseases, estimated from the incidence among relatives
FALCONER, D. S. (1965) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1965.tb00500.x · Cited by 1,626
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
The Use of Probability Paper for the Graphical Analysis of Polymodal Frequency Distributions
Harding, J. P. (1949) · Journal of the Marine Biological Association of the United Kingdom · doi:10.1017/s0025315400055259 · Cited by 670
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 623
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107331 · Cited by 622
Self-citationThe Familial Hyperlipoproteinemias
Marion, M. S. (1975) · Cited by 528
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
Cited by
Items 101–128 of 128
GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES
Austin, M., & Krauss, R. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92425-6 · Cited by 162
Nordestgaard, B. G., Tybjaerg-Hansen, A., & Lewis, B. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.1.6 · Cited by 159
“12-60 lipoprotein levels (IDL plus small VLDL) are grossly elevated while LDL levels typically are low(40); 2) chronic renal failure and non-insulin-dependent diabetes mellitus, in each of which lipoprotein abnormalities include elevated levels of Sf 12-60 lipoprotein(4142); and 3) familial combined hyperlipidemia, in…”
Hypertriglyceridemia in the genomic era: a new paradigm
Lewis, G. F., Xiao, C., & Hegele, R. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1062 · Cited by 152
Veenkamp (2002) · doi:10.1161/hq0202.104059 · Cited by 152
“‡Statistically significant effect for each of the following: (1) time, (2) group, and (3) time-group interaction with use of a linear mixed model (P 0.”
MethodCalabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., Bernini, F., & Franceschini, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.007 · Cited by 132
Heritabilities of Apolipoprotein and Lipid Levels in Three Countries
Beekman, M., Heijmans, B. T., Martin, N. G., Pedersen, N. L., Whitfield, J. B., DeFaire, U., van Baal, G. C. M., Snieder, H., Vogler, G. P., Slagboom, P. E., et al. (2002) · Twin Research · doi:10.1375/twin.5.2.87 · Cited by 133
“However, while these specific mutations have a profound implication for persons with monogenic familial syndromes, they explain only a minor proport ion of the populat ion variation in serum apolipoprotein and lipid levels (Goldstein et al., 1973).”
Chait, A., & Eckel, R. H. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0203 · Cited by 128
Molecular spectrum of autosomal dominant hypercholesterolemia in France
Marduel, M., Carrié, A., Sassolas, A., Devillers, M., Carreau, V., Di Filippo, M., Erlich, D., Abifadel, M., Marques-Pinheiro, A., Munnich, A., et al. (2010) · Human Mutation · doi:10.1002/humu.21348 · Cited by 115
“DNA testing provides an unequivocal diagnosis and allows the identification of affected relatives at an early age when they can be offered lifestyle advice and appropriate lipid-lowering therapies (Humphries et al. 2008).”
BackgroundThe genetics of familial combined hyperlipidaemia
Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Stehouwer, C. D. A., de Graaf, J., & Stalenhoef, A. F. H. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.15 · Cited by 109
“Adipose tissue dysfunction (1): triglycerides, stored in”
Ayyobi, A. F., McGladdery, S. H., McNeely, M. J., Austin, M. A., Motulsky, A. G., & Brunzell, J. D. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000077220.44620.9b · Cited by 103
Self-citationAbifadel, M., Rabès, J.-P., Jambart, S., Halaby, G., Gannagé-Yared, M.-H., Sarkis, A., Beaino, G., Varret, M., Salem, N., Corbani, S., et al. (2009) · Human Mutation · doi:10.1002/humu.21002 · Cited by 99
A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.
de Graaf, J., Couture, P., & Sniderman, A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0982 · Cited by 80
Hazzard, W. R., Warnick, G. R., Utermann, G., & Albers, J. J. (1981) · Metabolism · doi:10.1016/0026-0495(81)90223-7 · Cited by 77
Self-citationLDL physical and chemical properties in familial combined hyperlipidemia
Hokanson, J. E., Krauss, R. M., Albers, J. J., Austin, M. A., & Brunzell, J. D. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.452 · Cited by 76
Solanas-Barca, M., de Castro-Orós, I., Mateo-Gallego, R., Cofán, M., Plana, N., Puzo, J., Burillo, E., Martín-Fuentes, P., Ros, E., Masana, L., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.011 · Cited by 74
Combined hyperlipidemia: familial but not (usually) monogenic
Brahm, A. J., & Hegele, R. A. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000270 · Cited by 71
“Furthermore, the adjective ‘familial’ applied to CHL implicitly suggested that this phenotype was monogenic, akin to familial hypercholesterolemia [1,2].”
BackgroundInfluentialA new isoform of apolipoprotein E — Apo E-5 — Associated with hyperlipidemia and atherosclerosis
Yamamura, T., Yamamoto, A., Hiramori, K., & Nambu, S. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90019-4 · Cited by 70
Severe hypertriglyceridemia: role of familial and acquired disorders.
Chait, A., & Brunzell, J. D. (1983) · Metabolism · doi:10.1016/0026-0495(83)90184-1 · Cited by 69
The contribution of GWAS loci in familial dyslipidemias
Ripatti, P., Rämö, J. T., Söderlund, S., Surakka, I., Matikainen, N., Pirinen, M., Pajukanta, P., Sarin, A.-P., Service, S. K., Laurila, P.-P., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006078 · Cited by 60
“Familial combined hyperlipidemia (FCH), classically defined by elevations in serum total cholesterol (TC), triglycerides (TG), or both, in two or more first degree relatives, displays a prevalence of greater than 1% in Western populations [1, 2].”
Meijssen, S., van Dijk, H., Verseyden, C., Erkelens, D. W., & Cabezas, M. C. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000014079.98335.72 · Cited by 57
Meijssen, S., Cabezas, M. C., Twickler, T. B., Jansen, H., & Erkelens, D. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32015-0 · Cited by 53
Effect of nibbling versus gorging on cardiovascular risk factors: serum uric acid and blood lipids
Jenkins, D. J. A., Khan, A., Jenkins, A. L., Illingworth, R., Pappu, A. S., Wolever, T. M. S., Vuksan, V., Buckley, G., Rao, A. V., Cunnane, S. C., et al. (1995) · Metabolism · doi:10.1016/0026-0495(95)90066-7 · Cited by 52
Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway
van Himbergen, T. M., Otokozawa, S., Matthan, N. R., Schaefer, E. J., Buchsbaum, A., Ai, M., van Tits, L. J. H., de Graaf, J., & Stalenhoef, A. F. H. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196550 · Cited by 40
Brouwers, M. C. G. J., Konrad, R. J., van Himbergen, T. M., Isaacs, A., Otokozawa, S., Troutt, J. S., Schaefer, E. J., van Greevenbroek, M. M. J., Stalenhoef, A. F. H., & de Graaf, J. (2013) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.11.008 · Cited by 24
“Familial combined hyperlipidemia (FCHL) is the most common genetic dyslipidemia in western society and responsible for a substantial proportion of premature coronary events [1].”
BackgroundLiu, M.-L., Ylitalo, K., Vakkilainen, J., Nuotio, I., Valkonen, M., Lahdenperä, S., Viikari, J., & Taskinen, M.-R. (2002) · Annals of Medicine · doi:10.1080/078538902317338643 · Cited by 23
van Barlingen, H. H. J. J., Kock, L. A. W., de Man, F. H. A. F., Erkelens, D. W., & de Bruin, T. W. A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05703-x · Cited by 22
Arca, M., Montali, A., Pigna, G., Antonini, R., Antonini, T. M., Luigi, P., Fraioli, A., Mastrantoni, M., Maddaloni, M., & Letizia, C. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.021 · Cited by 21
A novel mouse model of familial combined hyperlipidemia and atherosclerosis
Chen, M.-J., Xu, Y.-T., Sun, L., Wang, Z.-H., Little, P. J., Wang, L., Xian, X.-D., Weng, J.-P., & Xu, S.-W. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01241-8 · Cited by 5
Metadata
- Authors
- Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1973-07-01
- Volume
- 52
- Issue
- 7
- Pages
- 1544-1568
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2142802148
- Cited by
- 1,443
- References
- 27
- FWCI
- 70.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.